Dare Bioscience Stock

Dare Bioscience Debt

The Debt of Dare Bioscience (DARE) as of Sep 14, 2026 is 2.10 M USD. In the previous year, Debt was 4.75 M USD — a change of -55.86% (lower).

Debt

2.10 MUSD

YoY

-55.86%

Last updated:

In 2026, Dare Bioscience's total debt was 2.10 M USD, a -55.86% change from the 4.75 M USD total debt recorded in the previous year.

The Dare Bioscience Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
370,000.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
3.91 M USD
Jan 1, 2024
4.75 M USD
Jan 1, 2025
2.10 M USD
The Dare Bioscience Debt history
YEARDebtYoY
2.10 MUSD-55.86%
4.75 MUSD+21.36%
3.91 MUSD—
0.00USD—
0.00USD-100.00%
370,000.00USD—
0.00USD—
0.00USD—
0.00USD-100.00%
700,000.00USD-96.56%
20.32 MUSD+551.28%
3.12 MUSD-0.45%
3.13 MUSD+9.24%
2.87 MUSD+2,159.06%
127,000.00USD—
Access this data via the Eulerpool API
Get Free API Key

Dare Bioscience Stock analysis

What does Dare Bioscience do? Dare Bioscience is one of the most popular companies on Eulerpool.

Debt Details

Understanding Dare Bioscience's Debt Structure

Dare Bioscience's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Dare Bioscience's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Dare Bioscience’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Dare Bioscience’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Dare Bioscience stock

Debt of Dare Bioscience is 2.10 M USD in 2026.

Debt of Dare Bioscience changed from 4.75 M USD to 2.10 M USD, representing a -55.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Dare Bioscience since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Dare Bioscience historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Dare Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Dare Bioscience